Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

622 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early or late initiation of dabigatran versus vitamin-K-antagonists in acute ischemic stroke or TIA: The PRODAST study.
Grosse GM, Hüsing A, Stang A, Kuklik N, Brinkmann M, Nabavi D, Sparenberg P, Weissenborn K, Gröschel K, Royl G, Poli S, Michalski D, Eschenfelder CC, Weimar C, Diener HC; PRODAST Investigators. Grosse GM, et al. Among authors: stang a. Int J Stroke. 2023 Dec;18(10):1169-1177. doi: 10.1177/17474930231184366. Epub 2023 Jul 4. Int J Stroke. 2023. PMID: 37306492 Free PMC article.
Association of antibiotic treatment with survival outcomes in treatment-naïve melanoma patients receiving immune checkpoint blockade.
Chorti E, Kowall B, Hassel JC, Schilling B, Sachse M, Gutzmer R, Loquai C, Kähler KC, Hüsing A, Gilde C, Thielmann CM, Zaremba-Montenari A, Placke JM, Gratsias E, Martaki A, Roesch A, Ugurel S, Schadendorf D, Livingstone E, Stang A, Zimmer L. Chorti E, et al. Among authors: stang a. Eur J Cancer. 2024 Mar;200:113536. doi: 10.1016/j.ejca.2024.113536. Epub 2024 Jan 18. Eur J Cancer. 2024. PMID: 38306840 Free article.
Efficacy and safety of oral factor Xa inhibitors versus vitamin-K antagonists in the early phase after acute ischemic stroke or TIA in the real-world setting: The PRODAST study.
Diener HC, Grosse GM, Hüsing A, Stang A, Kuklik N, Brinkmann M, Maurer GD, Soda H, Pohlmann C, Hilker-Roggendorf R, Popovic N, Kraft P, Mackert BM, Eschenfelder CC, Weimar C. Diener HC, et al. Among authors: stang a. Eur Stroke J. 2024 Sep;9(3):696-703. doi: 10.1177/23969873241242239. Epub 2024 Apr 3. Eur Stroke J. 2024. PMID: 38567789 Free PMC article.
Combining PSMA-PET and PROMISE to re-define disease stage and risk in patients with prostate cancer: a multicentre retrospective study.
Karpinski MJ, Hüsing J, Claassen K, Möller L, Kajüter H, Oesterling F, Grünwald V, Umutlu L, Kleesiek J, Telli T, Merkel-Jens A, Hüsing A, Kesch C, Herrmann K, Eiber M, Hoberück S, Meyer PT, Kind F, Rahbar K, Schäfers M, Stang A, Hadaschik BA, Fendler WP. Karpinski MJ, et al. Among authors: stang a. Lancet Oncol. 2024 Sep;25(9):1188-1201. doi: 10.1016/S1470-2045(24)00326-7. Epub 2024 Jul 29. Lancet Oncol. 2024. PMID: 39089299 Free article.
Impact of 18F-FDG PET/MRI on Therapeutic Management of Women with Newly Diagnosed Breast Cancer: Results from a Prospective Double-Center Trial.
Jannusch K, Umutlu L, Kirchner J, Bruckmann NM, Morawitz J, Herrmann K, Fendler WP, Bittner AK, Hoffmann O, Mohrmann S, Ruckhäberle E, Stuschke M, Schmid W, Giesel F, Häberle L, Esposito I, Budach W, Grueneisen J, Matuschek C, Kowall B, Stang A, Antoch G, Buchbender C. Jannusch K, et al. Among authors: stang a. J Nucl Med. 2024 Dec 3;65(12):1855-1861. doi: 10.2967/jnumed.124.268065. J Nucl Med. 2024. PMID: 39389629 Clinical Trial.
622 results